Ovary Neoplasm

11 registered clinical trials studyying Ovary Neoplasm — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy NCT06268665	University of California, Davis	Phase 2
Recruiting	Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells NCT06305299	UNC Lineberger Comprehensive Cancer Center	Phase 1
Not Yet Recruiting	SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours NCT06329323	Imperial College London	—
Completed	Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Expr NCT05292859	Alaunos Therapeutics	—
Unknown	Safety, Effectiveness and Operability of Using the New Tissue Containment System During Laparoscopic Ovarian C NCT04406597	China-Japan Friendship Hospital	N/A
Terminated	Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors NCT05194735	Alaunos Therapeutics	Phase 1 / Phase 2
Terminated	NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid NCT05252390	Nuvation Bio Inc.	Phase 1
Recruiting	Registry Platform Ovarian and Endometrial Cancer NCT05129969	iOMEDICO AG	—
Unknown	Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of O NCT05059782	Xi'an Jiaotong University	N/A
Terminated	A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) NCT05001282	Elucida Oncology	Phase 1 / Phase 2
Unknown	Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced a NCT03371693	Zhongnan Hospital	Phase 3